Nextgen Biomed Ltd (TLV:NXGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 61.70
+0.20 (0.33%)
Jul 16, 2025, 12:09 PM IDT
Nextgen Biomed Company Description
Nextgen Biomed Ltd develops topical treatment for psoriasis.
The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010.
Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Nextgen Biomed Ltd
| Country | Israel |
| Founded | 1990 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Harel Hershtik |
Contact Details
Address: 132 Azrieli Towers Round Building Tel Aviv, 6701101 Israel | |
| Phone | 972 9 950 0555 |
| Website | nextgen-biomed.com |
Stock Details
| Ticker Symbol | NXGN |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0010839301 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Harel Hershtik | Chief Executive Officer and GM |
| Efrat Hess | Senior Finance Officer |
| Dalia Mulakandov | Chief Financial Officer and Vice President of Finance |
| Anat Zimet Adv. BA, LLB, MBA | Legal Advisor and Company Secretary |